TF, CRP, TNF-α, and MCP-1 may not be attractive molecules to test for screening of CTEPH but may have value in determination of prognosis, which was not evaluated in our study. This evidence concerns the gene CCL2 and chronic thromboembolic pulmonary hypertension.